New eye injection shows promise for Diabetes-Related vision loss
Disease control
Completed
This study tested an experimental drug called AG-73305, given as an eye injection, in 25 adults with diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. The goal was to see if the drug is safe and can improve vision and reduce retinal swelli…
Phase: PHASE2 • Sponsor: Allgenesis Biotherapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC